Trial Outcomes & Findings for Liver Transplantation for Cholangiocarcinoma (NCT NCT00708877)

Results Overview

Determined mortality-related transplant outcomes.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

5 participants

Primary outcome timeframe

2 years

Results posted on

2013-07-30

Huntsman Cancer Institute recruited eligible participants between March 2007 and June 2011.

Participant milestones
Measure	Transplant All patients enrolled in study.
Overall Study STARTED	5
Overall Study COMPLETED	5
Overall Study NOT COMPLETED	0

Withdrawal data not reported

Liver Transplantation for Cholangiocarcinoma

Baseline characteristics by cohort
Measure	Transplant n=5 Participants All patients enrolled in study.
Age, Categorical <=18 years	0 Participants n=93 Participants
Age, Categorical Between 18 and 65 years	4 Participants n=93 Participants
Age, Categorical >=65 years	1 Participants n=93 Participants
Age Continuous	44.8 years STANDARD_DEVIATION 19.92 • n=93 Participants
Sex: Female, Male Female	0 Participants n=93 Participants
Sex: Female, Male Male	5 Participants n=93 Participants
Region of Enrollment United States	5 participants n=93 Participants

Timeframe: 2 years

Population: Entire cohort was used for analysis.

Determined mortality-related transplant outcomes.

Outcome measures
Measure	Transplant n=5 Participants The cohort was comprised of patients who received neoadjuvant chemoradiation and transplantation.
Transplant-related Mortality	0 participants Interval 0.0 to 52.0

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

University of Utah

Phone: 8015852708